A British biotech firm [Alchemab] believes patients who defy odds could hold the key in their blood, Tom Whipple writes
View the article
in Portfolio News
A British biotech firm [Alchemab] believes patients who defy odds could hold the key in their blood, Tom Whipple writes
We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.